BXP vs NBY · rev $895.7M vs $51.9M cap
Boston Properties Inc (BXP) versus NovaBay Pharmaceuticals Inc (NBY) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
NovaBay Pharmaceuticals Inc (NBY) is a biotechnology company listed on US.
Latest reported BXP revenue for 2026-06-30 was $895.7M. Net income was $68.6M. Revenue was up 2.7% from 2026-03-31 to 2026-06-30. BXP currently screens at market cap $12.12B.
NBY does not have a complete income-statement cache yet.
BXP currently screens at market cap $12.12B. NBY currently screens at market cap $51.9M.
Not investment advice. Open the BXP and NBY stock pages for the full models.
Not investment advice.